AHF: SCOTUS Skrmetti Ruling a ‘Triumph of Politics over Medical Science’
LOS ANGELES--(BUSINESS WIRE)-- AIDS Healthcare Foundation (AHF) issued the following statement today regarding the court’s 6 to 3 ruling earlier today ruling that Tennessee’s ban on gender-affirming care for transgender minors can remain in effect. (UNITED STATES v. SKRMETTI, ATTORNEY GENERAL AND REPORTER FOR TENNESSEE, ET AL.)
AHF statement:
“The Supreme Court decision represents the triumph of politics over medical science. Unlike the Supreme Court majority, we do not believe that medical decisions best made by doctors and families should be left up to the whims of politicians whipped up by right-wing media prejudice.”
AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 2.3 million individuals across 48 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. In January 2025, AHF received the MLK, Jr. Social Justice Award, The King Center’s highest recognition for an organization leading work in the social justice arena. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, and follow us on Instagram, Twitter, and TikTok.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250618102872/en/
Ged Kenslea, AHF Sr. Comms Dir.
(323) 791-5526
[email protected]
Source: AIDS Healthcare Foundation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TWO Announces Redemption of Series A, Series B and Series C Cumulative Redeemable Preferred Stock
- Form 8.3 - LondonMetric Property Plc & Schroder Real Estate Investment Trust Limited
- RAEK Opens Limited Design Partner Program for Creator Vault, Bringing Data Ownership to the Creator Economy
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share